Fulvestrant Powder Pharmaceutical Raw Materials Drugs for Breast Cancer

» farmacêutico » As drogas anti-tumorais » Fulvestrant Powder Pharmaceutical Raw Materials Drugs for Breast Cancer

  • Especificações

Buy Fulvestrant Powder Selective Estrogen Receptor Degrader Drug for Breast Cancer Online


Fulvestrant Specification

Nome do Produto: Fulvestrant
CAS: 129453-61-8
Padrão: USP35
Natural/Synthetic: Synthetic
Level: Pharmaceutical grade
Content: 99%
Aparência: white powder
Embalagem: 10G/Aluminum foil bag
Category: Matérias-primas farmacêuticas
Industry: Pharmaceuticals
Field: Steroid anti-estrogen drugs
Deferred product: Fulvestrant injection
Use: Estrogen receptor-positive locally advanced or metastatic mammary glands that can be used after anti-estrogen adjuvant therapy or during treatment, or after menopause (including natural menopause and artificial menopause) in anti-estrogen therapy cancer.
Usage and dosage: 1. Adult females (including elderly women): The recommended dose is once a month, once 250mg. There is a lack of information on the safety and efficacy of Chinese patients at higher doses. 2. Children and Adolescents: Since the safety and effectiveness of this product in children and adolescents have not been determined, the use of this product in this age group is not recommended. 3. Patients with impaired renal function: For patients with mild-to-moderate renal impairment (creatinine clearance ≥ 30 ml/min), there is no need to adjust the dose.


What is Fulvestrant?

Fulvestrant is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy.

Fulvestrant is given by injection into a muscle.


Fulvestrant Certificate of Analysis

Nome do Produto Fulvestrant
CAS. 129453-61-8 Embalagem exterior 10g/foil bag
Data de produção 2017-10-22 Validade 2019-10-18
norma aprovada USP35
Itens de análise Especificação Resultados
Aparência A white to off-white crystalline powder Conforme
Identificação 1、IR IR should conform to the standard Conforme
Specific rotaion +108°~ +115° 110.8°
6-Keto Fulvestran ≤0.1% 0.05%
∆6,7-Fulvestran ≤0.1% 0.08%
Fulvestrant sulfone ≤0.2% 0.11%
Fulvestrant extended ≤0.3% 0.08%
Fulvestrant sterol dimmer ≤0.8% 0.09%
Fulvestrant β-isomer ≤0.1% 0.06%
Any individual unspecified impurity ≤0.1% 0.03%
Total impurity ≤1.0% 0.7%
FulvestrantA 42%~48% 45.42%
FulvestrantB 52%~58% 54.58%
Resíduo de Lgnition ≤0.1% 0.03%
Drying loss ≤0.5% 0.30%
agua ≤0.5% 0.26%
Ensaio 98.0%~102% 99.2%
Conclusão Qualificado


Fulvestrant Side Effects

Very common (occurring in more than 10% of people) adverse effects include nausea, injection site reactions, weakness, and elevated transaminases. Common (between 1% e 10%) adverse effects include urinary tract infections, hypersensitivity reactions, loss of appetite, headache, blood clots in veins, hot flushes, vomiting, diarrhea, elevated bilirubin, rashes, and back pain.

Sales Contacts

Tel/Whatsapp: +86 17707567122
Wickr: mollyying
Telegrama: +86 185785209851
Skype: ying_2073
Mail: ying@wumeitech.com

Formulário de inquérito ( nós entraremos em contato o mais breve possível )

O email:

1 + 4 = ?

Talvez você gosta também

  • Categorias de Produtos

  • Postagens recentes

  • Compartilhar